RealTime Dynamix™: Renal Anemia, June 2016

Monthly report covering the dialysis and chronic kidney disease market for ESAs and IV Iron.  Additional insight on the development pipeline including receptivity to biosimilar ESAs and growing awareness of a novel class of anemia agents, the HIF-PH inhibitors. n=104 nephrologists

Download Report Overview

About Spherix Global Insights
Spherix Global Insights is a newly established business intelligence and market research company headquartered in Cambridge, MA with EU offices in Zug, Switzerland. We specialize in renal, autoimmune, neurologic and rare disease markets.

For more information contact: 
Telephone: (800) 661-0571